These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 35938615)

  • 1. Multiple Sclerosis and Aging: The Dynamics of Demyelination and Remyelination.
    Correale J; Ysrraelit MC
    ASN Neuro; 2022; 14():17590914221118502. PubMed ID: 35938615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Molecular Basis for Remyelination Failure in Multiple Sclerosis.
    Gruchot J; Weyers V; Göttle P; Förster M; Hartung HP; Küry P; Kremer D
    Cells; 2019 Aug; 8(8):. PubMed ID: 31382620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
    McLane LE; Bourne JN; Evangelou AV; Khandker L; Macklin WB; Wood TL
    J Neurosci; 2017 Aug; 37(31):7534-7546. PubMed ID: 28694334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cells of the oligodendroglial lineage, myelination, and remyelination.
    Miron VE; Kuhlmann T; Antel JP
    Biochim Biophys Acta; 2011 Feb; 1812(2):184-93. PubMed ID: 20887785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.
    Dulamea AO
    Adv Exp Med Biol; 2017; 958():91-127. PubMed ID: 28093710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
    Olsen JA; Akirav EM
    J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of oligodendroglial Stat3 is required for efficient remyelination.
    Steelman AJ; Zhou Y; Koito H; Kim S; Payne HR; Lu QR; Li J
    Neurobiol Dis; 2016 Jul; 91():336-46. PubMed ID: 27060559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory milieu at the multiple sclerosis lesion site and the challenges for remyelination.
    Galloway DA; Gowing E; Setayeshgar S; Kothary R
    Glia; 2020 May; 68(5):859-877. PubMed ID: 31441132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time is myelin: early cortical myelin repair prevents atrophy and clinical progression in multiple sclerosis.
    Lazzarotto A; Hamzaoui M; Tonietto M; Dubessy AL; Khalil M; Pirpamer L; Ropele S; Enzinger C; Battaglini M; Stromillo ML; De Stefano N; Filippi M; Rocca MA; Gallo P; Gasperini C; Stankoff B; Bodini B;
    Brain; 2024 Apr; 147(4):1331-1343. PubMed ID: 38267729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remyelination by surviving oligodendrocytes is inefficient in the inflamed mammalian cortex.
    Mezydlo A; Treiber N; Ullrich Gavilanes EM; Eichenseer K; Ancău M; Wens A; Ares Carral C; Schifferer M; Snaidero N; Misgeld T; Kerschensteiner M
    Neuron; 2023 Jun; 111(11):1748-1759.e8. PubMed ID: 37071991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid hormone alleviates demyelination induced by cuprizone through its role in remyelination during the remission period.
    Zhang M; Zhan XL; Ma ZY; Chen XS; Cai QY; Yao ZX
    Exp Biol Med (Maywood); 2015 Sep; 240(9):1183-96. PubMed ID: 25577802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attempts to Overcome Remyelination Failure: Toward Opening New Therapeutic Avenues for Multiple Sclerosis.
    Motavaf M; Sadeghizadeh M; Javan M
    Cell Mol Neurobiol; 2017 Nov; 37(8):1335-1348. PubMed ID: 28224237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
    Keirstead HS; Blakemore WF
    Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation stimulates remyelination in areas of chronic demyelination.
    Foote AK; Blakemore WF
    Brain; 2005 Mar; 128(Pt 3):528-39. PubMed ID: 15699059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligodendroglial lineage cells express nuclear p57kip2 in multiple sclerosis lesions.
    Pfeifenbring S; Metz I; Kremer D; Küry P; Hartung HP; Brück W
    Glia; 2013 Aug; 61(8):1250-60. PubMed ID: 23828667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal activity and NIBS in developmental myelination and remyelination - Current state of knowledge.
    Scheinok TJ; D'Haeseleer M; Nagels G; De Bundel D; Van Schependom J
    Prog Neurobiol; 2023 Jul; 226():102459. PubMed ID: 37127087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct patterns of glia repair and remyelination in antibody-mediated demyelination models of multiple sclerosis and neuromyelitis optica.
    Liu Y; Given KS; Owens GP; Macklin WB; Bennett JL
    Glia; 2018 Dec; 66(12):2575-2588. PubMed ID: 30240044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelin regulatory factor drives remyelination in multiple sclerosis.
    Duncan GJ; Plemel JR; Assinck P; Manesh SB; Muir FGW; Hirata R; Berson M; Liu J; Wegner M; Emery B; Moore GRW; Tetzlaff W
    Acta Neuropathol; 2017 Sep; 134(3):403-422. PubMed ID: 28631093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of neurofascin localization reveals early changes preceding demyelination and remyelination in multiple sclerosis.
    Howell OW; Palser A; Polito A; Melrose S; Zonta B; Scheiermann C; Vora AJ; Brophy PJ; Reynolds R
    Brain; 2006 Dec; 129(Pt 12):3173-85. PubMed ID: 17041241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial changes within axons in multiple sclerosis: an update.
    Campbell GR; Ohno N; Turnbull DM; Mahad DJ
    Curr Opin Neurol; 2012 Jun; 25(3):221-30. PubMed ID: 22543429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.